Crossref
Anastrozole: Repurposed drug could prevent thousands of breast cancer cases
BMJ · 2023
DOI: 10.1136/bmj.p2608 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMJ, 2023. Verfasst von Elisabeth Mahase. Beteiligte Einrichtung: The BMJ. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 2 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Breast NeoplasmsHumansFemaleAnastrozoleAromatase InhibitorsAntineoplastic Agents, HormonalNitrilesTamoxifen
Substanzen
AnastrozoleAromatase InhibitorsAntineoplastic Agents, HormonalNitrilesTamoxifen
Autor:innen und Institutionen
- The BMJ.
Zitieren
APA
Mahase, E. (2023). Anastrozole: Repurposed drug could prevent thousands of breast cancer cases. BMJ. https://doi.org/10.1136/bmj.p2608
Vancouver
Mahase E. Anastrozole: Repurposed drug could prevent thousands of breast cancer cases. BMJ. 2023. doi:10.1136/bmj.p2608
BibTeX
@article{Mahase2023,
author = {Mahase, Elisabeth},
title = {Anastrozole: Repurposed drug could prevent thousands of breast cancer cases},
journal = {BMJ},
year = {2023},
doi = {10.1136/bmj.p2608}
}
EUVIMED